SCHEMBL825809

SCHEMBL825809

C[C@@H](NC1CCNC1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.41
EPHX1 P07099 2/20 0.39
CPN1 P15169 2/20 0.37
CPB2 Q96IY4 2/20 0.37
SLC6A1 P30531 4/20 0.36
GABRA5 P31644 3/20 0.36
GABRB2 P47870 3/20 0.36
SLC6A11 P48066 3/20 0.36
SLC6A13 Q9NSD5 3/20 0.36
SLC6A12 P48065 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRA4 P48169 2/20 0.36
POLB P06746 1/20 0.36
GABRR1 P24046 1/20 0.36
TSHR P16473 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825689 1.00 KCNH2 (0.41) KCNH2EPHX1CPN1CPB2SLC6A1
SCHEMBL31109672 1.00 KCNH2 (0.41) KCNH2EPHX1CPN1CPB2SLC6A1
SCHEMBL6371477 0.89 CPN1 (0.45) EPHX1CPN1CPB2SLC6A1SLC6A11
SCHEMBL384885 0.89 CPN1 (0.45) EPHX1CPN1CPB2SLC6A1SLC6A11
SCHEMBL384884 0.89 CPN1 (0.45) EPHX1CPN1CPB2SLC6A1SLC6A11
SCHEMBL6371199 0.89 EPHX1 (0.47) EPHX1CPN1CPB2GABRA5GABRB2
SCHEMBL384923 0.89 EPHX1 (0.47) EPHX1CPN1CPB2GABRA5GABRB2
SCHEMBL384924 0.89 EPHX1 (0.47) EPHX1CPN1CPB2GABRA5GABRB2
SCHEMBL1801065 0.84 KCNH2 (0.40) KCNH2EPHX1SLC6A1GABRA5GABRB2
SCHEMBL1801069 0.84 KCNH2 (0.40) KCNH2EPHX1SLC6A1GABRA5GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536120-B2 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2013-09-17 US claimed
US-20130172242-A1 GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF MCGILL UNIVERSITY (CA) 2013-07-04 US claimed
EP-2582715-A2 GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF The Administrators of the Tulane Educational Fund (US) 2013-04-24 EP claimed
WO-2011159917-A2 GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2011-12-22 WO claimed
US-20090069245-A1 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2009-03-12 US claimed
EP-2021015-A2 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF The Administrators Of The Tulane Educational Fund (US) 2009-02-11 EP claimed
WO-2007127457-A9 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF UNIV TULANE (US) 2008-04-03 WO claimed
WO-2007127457-A2 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2007-11-08 WO claimed
EP-2582715-B1 GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2018-11-28 EP disclosed
US-9724381-B2 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2017-08-08 US disclosed
US-20170049849-A9 METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2017-02-23 US disclosed
US-9315546-B2 Growth hormone secretatogue receptor antagonists and uses thereof THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2016-04-19 US disclosed
US-20150031605-A1 METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF UNIV TULANE (US) 2015-01-29 US disclosed
US-8883721-B2 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof MCGILL UNIVERSITY (CA) 2014-11-11 US disclosed
WO-2011159917-A2 GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2011-12-22 WO disclosed
WO-2010132580-A2 METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2010-11-18 WO disclosed
US-20090069245-A1 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2009-03-12 US disclosed
EP-2021015-A2 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF The Administrators Of The Tulane Educational Fund (US) 2009-02-11 EP disclosed
WO-2007127457-A9 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF UNIV TULANE (US) 2008-04-03 WO disclosed
WO-2007127457-A2 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2007-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069245-A1 GHRELIN/GROWTH HORMONE RELEASING PEPTIDE/GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF GHSR, GHRHR, GIPR KCNH2 3722/4885EPHX1 4094/4885CPN1 3229/4885
US-20150031605-A1 METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF GHSR, GIPR, GHRHR KCNH2 4448/4885EPHX1 3900/4885CPN1 596/4885
US-20170049849-A9 METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF GHSR, GIPR, GHRHR KCNH2 4448/4885EPHX1 3900/4885CPN1 596/4885
US-20130172242-A1 GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF GHSR, GHRHR, GIPR KCNH2 3579/4885EPHX1 4132/4885CPN1 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.